Background: This study aimed to explore the client experience of long-term opiate substitution treatment (OST). Methods: A qualitative grounded theory study set in a UK rural community drug treatment service. Results: Continuous OST enabled stability and a sense of “normality.” Participants expressed relief at moving away from previous chaotic lifestyles and freedom from the persistent fear of opiate withdrawal. However, for some, being on a script made them feel withdrawn, lethargic, and unable to fully participate in mainstream society. Intrapersonal barriers (motivation and fear) were perceived as key barriers to abstinence. Conclusions: Participants experienced long-term OST as a transition between illicit drug use and recovery. Recover...
There is increasing recognition that recovery from heroin addiction is possible but there is limited...
• Entering and staying in treatment, coming off opioid substitution treatment (OST) and exiting stru...
Background The opioid antagonist extended-release naltrexone (XR-NTX) in the treatment of opioid use...
Using thematic analysis, this qualitative study investigates desistance from illicit drug use from t...
BACKGROUND Opioid dependence is associated with substantial medical, psychological and social proble...
Background Opioid maintenance treatment (OMT) is the most widely used treatment for opioid dependenc...
OBJECTIVE: To understand the most significant aspects of care experienced by people in opioid substi...
DATA AVAILABILITY : The data that support the findings of this study are available from the correspo...
Aims: Patient-reported outcomes have become an important source of information to guide service prov...
Background: Research indicates that 3% of people receiving opiate substitution treatment (OST) in th...
Introduction and Aims. The aim of this study was to examine heroin careers among former users to ass...
Background: Studies investigating the subjective experiences of long-term recovery from substance us...
Transitioning opioid-dependent patients from detoxification to long-term treatment: efficacy of inte...
Background: Approximately 3% of people receiving opioid substitution therapy (OST) in the UK manage ...
Objective: The objective of this article is to gain insight into how individuals who frequent open i...
There is increasing recognition that recovery from heroin addiction is possible but there is limited...
• Entering and staying in treatment, coming off opioid substitution treatment (OST) and exiting stru...
Background The opioid antagonist extended-release naltrexone (XR-NTX) in the treatment of opioid use...
Using thematic analysis, this qualitative study investigates desistance from illicit drug use from t...
BACKGROUND Opioid dependence is associated with substantial medical, psychological and social proble...
Background Opioid maintenance treatment (OMT) is the most widely used treatment for opioid dependenc...
OBJECTIVE: To understand the most significant aspects of care experienced by people in opioid substi...
DATA AVAILABILITY : The data that support the findings of this study are available from the correspo...
Aims: Patient-reported outcomes have become an important source of information to guide service prov...
Background: Research indicates that 3% of people receiving opiate substitution treatment (OST) in th...
Introduction and Aims. The aim of this study was to examine heroin careers among former users to ass...
Background: Studies investigating the subjective experiences of long-term recovery from substance us...
Transitioning opioid-dependent patients from detoxification to long-term treatment: efficacy of inte...
Background: Approximately 3% of people receiving opioid substitution therapy (OST) in the UK manage ...
Objective: The objective of this article is to gain insight into how individuals who frequent open i...
There is increasing recognition that recovery from heroin addiction is possible but there is limited...
• Entering and staying in treatment, coming off opioid substitution treatment (OST) and exiting stru...
Background The opioid antagonist extended-release naltrexone (XR-NTX) in the treatment of opioid use...